瞳孔計市場－2026-2031年預測

預計瞳孔計市場將從 2025 年的 530,398,000 美元成長到 2031 年的 779,397,000 美元，複合年成長率為 6.63%。

受神經系統疾病盛行率上升、技術創新和臨床應用範圍不斷擴大的推動，瞳孔計市場正經歷快速成長。由於磁振造影（MRI）和電腦斷層掃描（CT）等影像方式已證實腦部活動與瞳孔擴張之間存在直接關聯，因此，測量瞳孔擴張的瞳孔測量法對於理解各種潛在疾病的價值日益凸顯。這種診斷方法有助於更深入地了解認知過程，並提供有關正常眼功能和受疾病影響的腦部活動的見解。泛自閉症障礙、帕金森氏症、憂鬱症和焦慮症患者對刺激表現出異常的瞳孔測量反應。這拓寬了該技術的臨床效用，使其可用於多種神經和精神疾病的診斷。

主要市場促進因素

神經系統疾病的負擔

全球非傳染性神經系統疾病負擔日益加重，主要原因是人口老化。神經系統疾病的主要病因包括癲癇、頭痛和中風。瞳孔計透過測量眼球曲率來識別神經系統疾病，隨著患者群體的不斷擴大，對這類設備的需求也在成長。預計未來神經系統疾病患者人數將持續增加，醫療保健系統需要更先進的診斷工具來滿足不斷成長的患者群體的需求，因此，在預測期內，瞳孔計市場預計將保持持續成長。

政府和組織舉措

眾多政府機構和私人組織正致力於提高人們對神經系統疾病的認知，並改善醫療服務的可近性。國際神經調控學會（International Society for Neuromodulation）是一家致力於推動神經調控科學發展的非營利組織，它透過會議、同行評審出版物、教育材料和線上平台傳播訊息，促進神經調控技術的廣泛應用。這些提高公眾意識的努力以及醫療服務可近性的改善，正在幫助擴大瞳孔計市場，因為越來越多的醫護人員和患者認知到客觀神經系統評估的價值。

攜帶式瞳孔計的普及

預計在預測期內，攜帶式瞳孔計將實現最快的成長。攜帶式瞳孔計能夠快速、準確地擷取瞳孔影像，用於診斷包括阿茲海默症在內的神經系統疾病。攜帶式的便利性和行動性正在推動其發展和應用範圍的不斷擴大。 NeurOptics是一家領先的攜帶式瞳孔計製造商，其產品廣泛應用於重症監護和臨床研究領域。此外，Adaptica等公司正在開發混合型攜帶式設備，例如整合了瞳孔測量功能的2WIN，展現了在外形和功能整合的創新。

視訊瞳孔計技術

視訊瞳孔儀可以記錄瞳孔擴張的整個過程，有助於了解瞳孔變化及其根本原因。 NeuroOptics 是一家專注於瞳孔測量科學的公司，運用最尖端科技幫助醫生提升患者照護品質。該公司已開發出多種用於重症監護和臨床研究的視訊瞳孔儀。 NPi-200 重症監護視訊瞳孔儀配備紅外線相機、中央處理器、精密光學元件和 LED 光源。其視訊功能可以記錄瞳孔大小和反應隨時間的變化，提供靜態測量無法獲得的動態數據。

技術進步

技術進步大大提高了瞳孔計的精度、效用和操作便利性。傳統的瞳孔計使用可見光測量瞳孔反應，而紅外線瞳孔測量已成為現代設備的標準配置。紅外線測量具有高精度和高可靠性，尤其是在各種光照條件下，並且消除了傳統測量中常見的環境因素干擾。

現代瞳孔計配備了高解析度相機和尖端成像技術，能夠捕捉到清晰、細緻的瞳孔照片。此外，人工智慧演算法的開發和應用也進一步提升了診斷能力。人工智慧的整合實現了更精細的模式識別，能夠識別出人眼難以察覺的細微瞳孔反應異常，從而提高診斷的靈敏度和特異性。

區域趨勢

在北美市場主導地位

由於神經系統疾病發病率上升和視力相關問題日益增多，北美佔據了瞳孔計市場的大部分佔有率。瞳孔計在美國各種醫療環境中的廣泛應用預計將推動市場佔有率的成長。美國領先的NeuroOptics等主要企業正在開發先進的瞳孔計以提高診斷準確性。為了將市場拓展到傳統神經系統應用之外，各公司正在探索瞳孔計在各種重症監護領域的潛在應用，並致力於將產品用途擴展到其他醫療領域。

亞太地區成長潛力

預計亞太地區在預測期內將展現出顯著的成長潛力。透過各種線上市場和供應商增加瞳孔計的獲取途徑，有望推動區域市場的擴張。 NeurOptics、強生視力保健和Konan Medical等主要國際製造商均透過其區域子公司銷售瞳孔計。 NeurOptics透過合作夥伴公司進行銷售，例如印度的Hansraj Nayyar Medical India、日本的IMI Corporation和韓國的Neuroplus。 NIDEK等國際公司正在提高該地區瞳孔計的可及性和可用性，以支持這個高成長地區的市場發展。

戰略產業方法

瞳孔儀市場的參與企業積極參與行業展會、展覽和會議，以提高人們對檢測法的認知度並展示其產品線。業內相關人員正在開發攜帶式設備，以克服移動性方面的挑戰，並提高設備在各種情況下的易用性。各公司正在開發可安裝在行動裝置上的尖端軟體，以實現遠端瞳孔測量，從而擴大其可及性並實現即時醫療應用。

近期進展包括：2022年12月，NeuroOptics的神經瞳孔指數和自動瞳孔測量技術被納入修訂後的歐洲復甦委員會（ERC）和歐洲重症監護醫學會（ESICM）復甦後護理指南，作為支持心臟驟心臟麻痹患者神經系統預後的客觀檢測法。 2022年5月，NeuroOptics開始在包括英國、法國、義大利、愛爾蘭、澳洲和紐西蘭在內的15個國家銷售NPi-300瞳孔計。

本報告的主要優勢：

• 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
• 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
• 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
• 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
• 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

• 歷史資料（2021-2025 年）和預測資料（2026-2031 年）
• 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
• 競爭對手定位、策略和市場佔有率分析
• 按業務板塊和地區（國家）分類的收入成長和預測分析
• 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

• 市場概覽
• 市場定義
• 分析範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策和法規
• 策略建議

第4章 技術展望

第5章 瞳孔計市場：依類型分類

• 介紹
• 影片
• 數位的

第6章 瞳孔計市場：移動性別

• 介紹
• 桌面型
• 攜帶式的

第7章 瞳孔計市場：依應用領域分類

• 介紹
• 眼科
• 神經科
• 腫瘤學
• 其他

第8章 瞳孔計市場：依地區分類

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 企業合併、協議、商業合作
• 競爭對手儀錶板

第10章：公司簡介

• NeurOptics, Inc.
• Adaptica
• Essilor Instruments USA
• Haag-Streit Group
• Johnson & Johnson Vision
• Visionix
• NIDEK CO., LTD.
• Reichert Technologies
• SCHWIND eye-tech-solutions
• US Ophthalmi

第11章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 分析方法
• 簡稱

The pupillometer market is anticipated to grow at a 6.63% CAGR, reaching USD 779.397 million in 2031 from USD 530.398 million in 2025.

The pupillometer market is experiencing rapid growth driven by rising neurological disorder prevalence, technological innovation, and expanding clinical applications. Pupillometry-the measurement of pupil dilation to understand various underlying diseases-has become increasingly valuable as imaging modalities including MRI and CT have demonstrated direct correlations between brain activity and pupil dilation. This diagnostic approach aids deeper understanding of cognitive processes and provides insights into both normal eye functionality and illness-affected brain activity. Individuals with autism spectrum disorder, Parkinson's disease, depression, and anxiety display aberrant pupillometry responses to stimuli, expanding the technology's clinical utility across diverse neurological and psychiatric conditions.

Primary Market Drivers

Neurological Disorder Burden

The global burden of non-communicable neurological illnesses is rising, primarily driven by aging populations. Principal causes of neurological illnesses include epilepsy, headache conditions, and stroke. Pupillometers measure eye curvature to identify neurological problems, creating rising demand for these instruments as patient populations expand. The anticipated growth in persons affected by neurological illnesses positions the pupillometer market for sustained development throughout the projected period, as healthcare systems require increasingly sophisticated diagnostic tools for growing patient populations.

Government and Organizational Initiatives

Numerous governmental and commercial organizations are working to increase understanding of neurological illnesses and enhance healthcare access. The International Neuromodulation Society, a non-profit organization devoted to advancing neuromodulation science, disseminates information and encourages neuromodulation through conferences, peer-reviewed publications, educational material, and online platforms. These awareness campaigns and healthcare access advancements drive pupillometer market expansion by creating more informed healthcare providers and patients who understand the value of objective neurological assessment.

Hand-Held Pupillometer Adoption

Hand-held pupillometers are anticipated to develop at the quickest rate during the projected period. Portable pupillometers enable users to quickly and precisely capture pupil images for diagnosing neurological conditions including Alzheimer's disease. The hand-held format's convenience and mobility are driving increased development and popularity. NeurOptics represents a leading manufacturer of handheld pupillometers for critical care and practical research applications. Additionally, companies like Adaptica have developed hybrid hand-held devices such as 2WIN that incorporate pupillometry functionality, demonstrating innovation in form factor and feature integration.

Video Pupillometer Technology

Video pupillometers enable recording of complete pupil dilation processes, facilitating understanding of variations and their underlying causes. NeurOptics, specializing in pupillometry science, employs cutting-edge technology enabling physicians to deliver improved patient care. The company has developed various video pupillometers for critical care and practical research. The NPi-200 video pupillometer for critical care features infrared cameras, CPUs, highly accurate optics, and LED light sources. Video functionality aids documenting how pupil size and response vary over time, providing temporal data unavailable through static measurements.

Technological Advancement

Technological improvements have substantially enhanced pupillometer accuracy, usefulness, and usability. While traditional pupillometers measured pupillary responses using visible light, infrared pupillometry has become the standard in contemporary devices. Infrared light provides greater precision and dependability, particularly under diverse lighting situations, eliminating environmental variables that previously complicated measurements.

Modern pupillometers incorporate high-resolution cameras with cutting-edge imaging capabilities to capture accurate, detailed pupil photographs. Additionally, artificial intelligence algorithms are being developed and implemented to enhance diagnostic capabilities. AI integration enables more sophisticated pattern recognition, potentially identifying subtle pupillary response abnormalities that might escape human observation, expanding diagnostic sensitivity and specificity.

Regional Dynamics

North American Market Leadership

North America holds the majority of pupillometer market share due to rising neurological illness frequency and vision-related issues. Acceptance and installation of pupillometers across diverse U.S. settings is anticipated to fuel market share growth. Major industry companies like NeurOptics, headquartered in the United States, are developing sophisticated pupillometers for improved diagnosis. Companies are investigating pupillometer applications in various critical care domains to broaden product utility for additional medical problems, expanding the addressable market beyond traditional neurological applications.

Asia Pacific Growth Potential

The Asia Pacific region is anticipated to demonstrate major growth potential during the projected period. Expanding pupillometer access through various online marketplaces and providers is expected to support regional market expansion. Major international manufacturers including NeurOptics, Johnson & Johnson Vision, and Konan Medical offer pupillometers through regional subsidiaries. NeurOptics distributes through partners in India, Japan, and South Korea-Hansraj Nayyar Medical India, IMI Co., and Neuroplus. International players like NIDEK have improved regional pupillometer access and availability, supporting market development in this high-growth region.

Strategic Industry Approaches

Pupillometer market participants engage in trade events, exhibits, and conferences to raise knowledge of pupillometry and showcase product ranges. Industry players develop portable devices addressing mobility concerns and improving device usability across varied contexts. Companies have developed cutting-edge software installable on mobile devices to complete pupillometry processes remotely, expanding accessibility and enabling point-of-care applications.

Recent developments include December 2022 incorporation of NeurOptics' Neurological Pupil Index and automated pupillometry into updated European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for post-resuscitation care as objective measurements supporting neurological prognosis in cardiac arrest patients. In May 2022, NeurOptics launched the NPi-300 pupillometer across 15 nations including the United Kingdom, France, Italy, Ireland, Australia, and New Zealand.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Pupillometer Market Segmentation

• By Type
• Video
• Digital
• By Mobility
• Table-top
• Hand-held
• By Application
• Ophthalmology
• Neurology
• Oncology
• Others
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PUPILLOMETER MARKET BY TYPE

• 5.1. Introduction
• 5.2. Video
• 5.3. Digital

6. PUPILLOMETER MARKET BY MOBILITY

• 6.1. Introduction
• 6.2. Table-top
• 6.3. Hand-held

7. PUPILLOMETER MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Ophthalmology
• 7.3. Neurology
• 7.4. Oncology
• 7.5. Others

8. PUPILLOMETER MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. NeurOptics, Inc.
• 10.2. Adaptica
• 10.3. Essilor Instruments USA
• 10.4. Haag-Streit Group
• 10.5. Johnson & Johnson Vision
• 10.6. Visionix
• 10.7. NIDEK CO., LTD.
• 10.8. Reichert Technologies
• 10.9. SCHWIND eye-tech-solutions
• 10.10. US Ophthalmi

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations